Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial

Authors: Benjamin J. Bruno, Joshua C. Weavil, Jonathan Ogle, Nachiappan Chidambaram, Elizabeth J. Carey, Christopher J. Danford, Zachary P. Fricker, Joseph S. Galati, William M. Lee, Parvez S. Mantry, Kirti Shetty, Anthony DelConte, Mahesh V. Patel, Jennifer C. Lai, Arun J. Sanyal

Published: 2024-11-08

DOI: 10.1097/hep.0000000000001146

Source: Full article

---

Abstract

Background and Aims: